The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching US$29.13 billion by 2030. The growing number of elderly ...

Ambrosia, a global leader in real-time health monitoring, has launched India's first 24x7 real-time glucose and stress ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and scientific fact-checking for the global public.

Maowasha say a Continuous Glucose Monitoring (CGM) device consists of a sensor and a transmitter. He says the transmitter can be connected to an individual phone which allows one to read numbers.

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.

Market OverviewThe Global Smart Medical Devices Market is valued at USD 90.55 Billion in 2024 and is projected to reach a ...

A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...

A Raman spectroscopy device was used to non-invasively monitor their blood glucose over a two day period. This uses a near-infrared light of 830nm wavelength, positioned over the person’s thumb.

The global vital signs monitoring devices market, valued at USD 25.62 billion in 2022, is projected to grow at a CAGR of 12.7 ...